Nomura Holdings’s AC Immune ACIU Stock Holding History

Nomura Holdings’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,000	Closed	-$79.8K	–	1503
2024 Q2	$79.8K	Buy	+20,000	New	+$66.2K	﹤0.01%	1697

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Nomura Holdings's ACIU Position: Q3 2024 in Review

Nomura Holdings sold out of AC Immune (ACIU) in Q3 2024, closing a stake of 20,000 shares — an estimated $79.8K sold.

Nomura Holdings first reported a position in ACIU in Q2 2024 and held it in 1 quarter. The position peaked at $79.8K in Q2 2024. 43 funds tracked by Wall St. Rank hold ACIU as of Q3 2024.

Nomura Holdings reported no remaining AC Immune position as of Q3 2024 after selling out during the quarter.
Nomura Holdings sold 20,000 AC Immune shares in Q3 2024, an estimated $79.8K.
Nomura Holdings first reported a position in AC Immune in Q2 2024 and held it in 1 quarter.
Nomura Holdings's AC Immune position peaked at $79.8K in Q2 2024.
43 funds tracked by Wall St. Rank held AC Immune as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.